Article
Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects.
International journal of radiation oncology, biology, physics - 1 Mar 2010
Bentzen Søren M, Parliament Matthew, Deasy Joseph O, Dicker Adam, Curran Walter J, Williams Jacqueline P, Rosenstein Barry S
Abstract excerpt
Biomarkers are of interest for predicting or monitoring normal tissue toxicity of radiation therapy. Advances in molecular radiobiology provide novel leads in the search for normal tissue biomarkers with sufficient sensitivity and specificity to become clinically useful. This article reviews examples of studies of biomarkers as predictive markers, as response markers, or as surrogate endpoints for radiation side...
Topics
Join the communities discussing this publication.
